Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rivaroxaban plus Aspirin vs Acenocoumarol for Recurrent VTE
NCT05515120Phase 3Completed
- Sponsor
- Instituto Mexicano del Seguro Social
- Start
- Jan 2021
- Primary completion
- Jan 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of aspirin in venous thromboembolism (VTE), sponsored by Instituto Mexicano del Seguro Social. Started Jan 2021; status: completed.
02
Drugs
aspirin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT05515120.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05515120.